(Q29544964)

English

Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension

scientific article (publication date: 2002)

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/11790158

1 reference

Europe PubMed Central

Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/11790158

arterial hypertension

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ezequiel Balmori Melian

1

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/11790158

Karen L Goa

2

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/11790158

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/11790158

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/11790158

62

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/11790158

1

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/11790158

107-133

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/11790158

Role of prostacyclin in the treatment of primary pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostacyclin and beraprost sodium as suppressors of activated rat polymorphonuclear leukocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition by beraprost sodium of thrombin-induced increase in endothelial macromolecular permeability

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three-month therapy with calcium-heparin in comparison with ticlopidine in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The place of prostacyclin in the clinical management of primary pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-term hemodynamic effect of a new oral PGI2 analogue, beraprost, in primary and secondary pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): a double-blind, randomised, placebo-controlled trial. The European TAO Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protective effect of beraprost sodium, a stable prostacyclin analogue, in development of monocrotaline-induced pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral vasoactive medication in intermittent claudication: utile or futile?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Familial primary pulmonary hypertension: clinical patterns

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double blind placebo controlled trial of intravenous prostacyclin (PGI2) in 108 patients with ischaemic peripheral vascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary hypertension: its assessment and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin I2 analog enhances the expression of urokinase-type plasminogen activator and wound healing in cultured human fibroblast

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coexistent pulmonary and portal hypertension: morphologic and clinical features

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent claudication: its natural course

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Raynaud's phenomenon

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Orally active prostacyclin analogue in primary pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of antiplatelet effects of FK409, a spontaneous nitric oxide releaser, with those of TRK-100, a prostacyclin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recognition and management of pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oral prostacyclin derivative: a study in healthy male subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitory effects of beraprost on platelet aggregation: comparative study utilizing two methods of aggregometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic effect of ticlopidine, a new inhibitor of platelet aggregation, on chronic arterial occlusive diseases, a double-blind study versus placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The contractile mechanism of beraprost sodium, a stable prostacyclin analog, in the isolated canine femoral vein

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fate in intermittent claudication: outcome and risk factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary pulmonary hypertension and cirrhosis: are they related?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostacyclin in primary pulmonary hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical treatment of peripheral arterial disease and claudication

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ticlopidine: a new platelet aggregation inhibitor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PGI2 analogue, sodium beraprost, suppresses superoxide generation in human neutrophils by inhibiting p47phox phosphorylation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localisation and stimulation of prostacyclin production in vascular cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostacyclin and PGE1 treatment of pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful therapy of advanced arteriosclerosis obliterans with prostacyclin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of beraprost, a stable prostacyclin analogue, on red blood cell deformability impairment in the presence of hypercholesterolemia in rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on the antiplatelet effect of the stable epoprostenol analogue beraprost sodium and its mechanism of action in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A stable prostacyclin analog, beraprost sodium, attenuates platelet accumulation and preservation-reperfusion injury of isografts in a rat model of lung transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of beraprost Na, a stable prostacyclin analog, on animal models of stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacologic management of peripheral vascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

General pharmacology of beraprost sodium. 1st communication: effect on the central nervous system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis and treatment of pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardioprotective effects of beraprost sodium against experimental ischemia and reperfusion as compared with propranolol and diltiazem

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of pseudointimal hyperplasia by a novel prostacyclin analogue: beraprost

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific binding of the new stable epoprostenol analogue beraprost sodium to prostacyclin receptors on human and rat platelets

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of intermittent claudication and its effect on mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of beraprost sodium on peripheral circulation insufficiency in rats and rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How to manage primary pulmonary hypertension. Giving hope to patients with a life-threatening illness.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vasodilator actions of TRK-100, a new prostaglandin I2 analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary hypertension and selective pulmonary vasodilators in acute lung injury.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protective effect of beraprost sodium, a stable prostacyclin analogue, on cardiac allograft vasculopathy in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epoprostenol in primary pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelial control of cell migration and proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The in vitro and ex vivo antiplatelet effect of TRK-100, a stable prostacyclin analog, in several species

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of beraprost sodium (Procylin), a stable prostaglandin I2 analogue, on a dorsal skin flap model in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

State of the art--treatment of peripheral occlusive arterial disease (POAD) with drugs vs. vascular reconstruction or amputation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of beraprost sodium, a stable prostacyclin analogue, on pulmonary thromboembolism in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-inflammatory effects of beraprost sodium, a stable analogue of PGI2, and its mechanisms.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thromboangiitis obliterans (Buerger's disease).

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life assessment in therapeutic trials: rationale for and presentation of a more appropriate instrument

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamic profile of prostacyclin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A dose-effect study of beraprost sodium in intermittent claudication

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytoprotective action of beraprost sodium against peroxide-induced damage in vascular endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11790158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-200262010-00005

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/11790158

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/11790158

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q29544964&oldid=2177960577"